Pancreatic Masses pp 319-327 | Cite as
Recent Advances and Novel Treatments of Pancreatic Masses
Chapter
Abstract
The advent of linear echoendoscopic ultrasound (EUS) in the 1990s has transformed EUS from a purely diagnostic modality to a platform for advanced diagnostic and therapeutic applications. The development of EUS-guided celiac ganglion neurolysis started a new era in EUS-guided techniques, where the fine needle has become the vehicle for delivery of various ablative agents, chemotherapeutic agents, and miniature devices. The following is an overview of recent advances and novel EUS-guided treatments of pancreatic tumors, including EUS-guided radiofrequency ablation, EUS-guided antitumor agents, and EUS-guided photodynamic therapy.
Keywords
Endoscopic ultrasound Radiofrequency ablation Gene therapy Immunotherapy Photodynamic therapyReferences
- 1.Fegrachi S, et al. Radiofrequency ablation for unresectable locally advanced pancreatic cancer: a systematic review. HPB (Oxford). 2014;16(2):119–23.CrossRefGoogle Scholar
- 2.Goldberg SN, et al. EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc. 1999;50(3):392–401.CrossRefPubMedGoogle Scholar
- 3.Carrara S, et al. Endoscopic ultrasound-guided application of a new hybrid cryotherm probe in porcine pancreas: a preliminary study. Endoscopy. 2008;40(4):321–6.CrossRefPubMedGoogle Scholar
- 4.Carrara S, et al. Endoscopic ultrasound-guided application of a new internally gas-cooled radiofrequency ablation probe in the liver and spleen of an animal model: a preliminary study. Endoscopy. 2008;40(9):759–63.CrossRefPubMedGoogle Scholar
- 5.Petrone MC, et al. US-guided application of a new hybrid probe in human pancreatic adenocarcinoma: an ex vivo study. Gastrointest Endosc. 2010;71(7):1294–7.CrossRefPubMedGoogle Scholar
- 6.Varadarajulu S, Jhala NC, Drelichman ER. EUS-guided radiofrequency ablation with a prototype electrode array system in an animal model (with video). Gastrointest Endosc. 2009;70(2):372–6.CrossRefPubMedGoogle Scholar
- 7.Gaidhane M, et al. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) of the pancreas in a porcine model. Gastroenterol Res Pract. 2012;2012:431451.PubMedCentralCrossRefPubMedGoogle Scholar
- 8.Kim HJ, et al. EUS-guided radiofrequency ablation of the porcine pancreas. Gastrointest Endosc. 2012;76(5):1039–43.CrossRefPubMedGoogle Scholar
- 9.Arcidiacono PG, et al. Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer. Gastrointest Endosc. 2012;76(6):1142–51.CrossRefPubMedGoogle Scholar
- 10.Pai M, et al. Endoscopic ultrasound guided radiofrequency ablation (EUS- RFA) for pancreatic ductal adenocarcinoma. Gut. 2013;62:A153.CrossRefGoogle Scholar
- 11.Chang KJ, et al. Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma. Cancer. 2000;88(6):1325–35.CrossRefPubMedGoogle Scholar
- 12.Mulvihill S, et al. Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial. Gene Ther. 2001;8(4):308–15.CrossRefPubMedGoogle Scholar
- 13.Hecht JR, et al. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res. 2003;9(2):555–61.PubMedGoogle Scholar
- 14.Hecht JR, et al. EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointest Endosc. 2012;75(2):332–8.PubMedCentralCrossRefPubMedGoogle Scholar
- 15.Herman JM, et al. Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results. J Clin Oncol. 2013;31(7):886–94.CrossRefPubMedGoogle Scholar
- 16.Nakai Y, Chang KJ. Endoscopic ultrasound-guided antitumor agents. Gastrointest Endosc Clin N Am. 2012;22(2):315–24. x.CrossRefPubMedGoogle Scholar
- 17.Irisawa A, et al. Endoscopic ultrasound-guided fine-needle injection of immature dendritic cells into advanced pancreatic cancer refractory to gemcitabine: a pilot study. Pancreas. 2007;35(2):189–90.CrossRefPubMedGoogle Scholar
- 18.Dougherty TJ, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90(12):889–905.PubMedCentralCrossRefPubMedGoogle Scholar
- 19.Agostinis P, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61(4):250–81.PubMedCentralCrossRefPubMedGoogle Scholar
- 20.Bown SG, et al. Photodynamic therapy for cancer of the pancreas. Gut. 2002;50(4):549–57.PubMedCentralCrossRefPubMedGoogle Scholar
- 21.Huggett MT, et al. Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer. Br J Cancer. 2014;110(7):1698–704.PubMedCentralCrossRefPubMedGoogle Scholar
- 22.Yusuf TE, Matthes K, Brugge WR. EUS-guided photodynamic therapy with verteporfin for ablation of normal pancreatic tissue: a pilot study in a porcine model (with video). Gastrointest Endosc. 2008;67(6):957–61.CrossRefPubMedGoogle Scholar
- 23.Hirooka Y, Itoh A, Kawashima H, Hara K, Nonogaki K, Kasugai T, Ohno E, Ishikawa T, Matsubara H, Ishigami M, Katano Y, Ohmiya N, Niwa Y, Yamamoto K, Kaneko T, Nieda M, Yokokawa K, Goto H. A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer. Pancreas. 2009;38(3):e69–74.Google Scholar
Copyright information
© Springer International Publishing Switzerland 2016